XEMBIFY 200 mg/mL

XEMBIFY 200 mg/mL is a subcutaneous immune globulin solution used to treat immune deficiencies. This product supports the immune system and is administered via subcutaneous injection.

XEMBIFY 200 mg/mL is primarily used to manage primary immune deficiencies. This immune globulin subcutaneous solution helps to replenish antibodies in individuals who cannot produce sufficient amounts naturally. It is often prescribed to support the immune system in conditions where the body's defense mechanisms are compromised.

Common effects of XEMBIFY 200 mg/mL may include localized reactions at the injection site, such as redness, swelling, or discomfort. Some individuals may experience mild systemic reactions like headache or fatigue. These effects are generally temporary and subside with continued use.

XEMBIFY 200 mg/mL should be handled with care to ensure proper administration. It is important to follow the prescribed guidelines for subcutaneous injection to minimize the risk of adverse reactions. Always consult a healthcare provider before starting or stopping any treatment.

XEMBIFY 200 mg/mL may interact with certain medications, particularly those that affect the immune system. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances that affect the immune system should be used with caution.